Cart
sales@molnova.com
BDC2.5 mimotope 1040-31 TFA
CAS No. ——
BDC2.5 mimotope 1040-31 TFA( —— )
Catalog No. M30300 CAS No. ——
This is a strongly agonistic peptide (mimotope) for diabetogenic T cell clone BDC2.5.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBDC2.5 mimotope 1040-31 TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionThis is a strongly agonistic peptide (mimotope) for diabetogenic T cell clone BDC2.5.
-
DescriptionThis is a strongly agonistic peptide (mimotope) for diabetogenic T cell clone BDC2.5.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight1462.63
-
Molecular FormulaC65H98F3N17O16S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Tyr}{Val}{Arg}{Pro}{Leu}{Trp}{Val}{Arg}{Met}{Glu}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Dai YD, et al. A peptide of glutamic acid decarboxylase 65 can recruit and expand a diabetogenic T cell clone, BDC2.5, in the pancreas. J Immunol. 2005 Sep 15;175(6):3621-7.
molnova catalog
related products
-
5-(5-methyl-1H-1,2,4...
5-(5-methyl-1H-1,2,4-triazol-3-yl)-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole can be used in the synthesis of heterocyclic compounds to inhibit HIF pathway activity.
-
T-3364366
Raclopride a selective antagonist of D2 dopamine receptor with Ki value of 1.8 nM.
-
Ataquimast
Ataquimast is used in curing advanced receptor-positive breast cancer.
